Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2010
10/20/2010CN101862400A Dehumidifying itching-relieving gels and preparation method thereof
10/20/2010CN101862384A Medicament for treating leucoderma
10/20/2010CN101862374A Lotus plumule and new application of extractive thereof
10/20/2010CN101862368A Medicament for treating leucoderma
10/20/2010CN101862352A Special health-care lubricating liquid
10/20/2010CN101862347A Disinfectant
10/20/2010CN101862342A External medicament for treating dermatophytosis
10/20/2010CN101862341A Application of Spinosad for wound healing
10/20/2010CN101862287A Compound acne-removing pearl powder with aluminum oxide-coated surface
10/20/2010CN101862233A Drug-delivery endovascular stent and method for treating restenosis
10/20/2010CN101361825B Traditional Chinese medicine formulation for treating alopecia
10/20/2010CN101244258B Use of TAT-N25 polypeptide in treating cell growth exception dermatosis such as psoriasis
10/20/2010CN101234148B Pure Chinese medicine powder for treating bedsore, scald and burn
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816412 Mixture of monomer, promoter, solvent and crosslinking agent; skin contact adhesive
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816358 Pharmaceutical formulations comprising N,N′-disubstituted piperazine compounds
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010US7816335 Therapeutic compounds and methods
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2458853C Use of fucans in the treatment of adhesions, arthritis and psoriasis
10/19/2010CA2454006C Pullulan-containing powder, the process for the same and use thereof
10/19/2010CA2390526C Sequence specific dna recombination in eukaryotic cells
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2286837C Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use
10/19/2010CA2178396C Enhancing keratinocyte migration and proliferation with clostridiopeptidase-a-collagenase
10/14/2010WO2010117258A1 A method of synthesising an amino acid derivative of azelaic acid
10/14/2010WO2010117241A2 Composition for prevention or treatment of hypertrophic scars or keloids
10/14/2010WO2010117199A2 Coenzyme q10 nanoparticles, preparation method thereof and composition containing said nanoparticles
10/14/2010WO2010117170A2 Pharmaceutical composition for treating or preventing burn injuries
10/14/2010WO2010117050A1 Solid preparation containing dibenz[b,e]oxepine derivative
10/14/2010WO2010117043A1 Method for recovering hair-growing ability of hair follicles, and cell transplantation tool
10/14/2010WO2010116099A1 Method for preparing molecular complexes between adapalene and cyclodextrins
10/14/2010WO2010115945A1 Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof
10/14/2010WO2010094452A3 Composition comprising n2 - (1-oxohexadecyl) - lysyl - valyl - lysine for treating rosacea and its symptoms
10/14/2010WO2010082175A3 Kxk-peptide compositions for cosmetic and dermo-pharmaceutic uses
10/14/2010WO2010078580A3 Immunotherapy for contact dermatitis using co-signal regulation
10/14/2010WO2010065085A3 Methods and compositions for treating or preventing pruritis
10/14/2010US20100261795 Antiacneic compositions
10/14/2010US20100261784 Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
10/14/2010US20100261772 Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators
10/14/2010US20100261769 Topical Compositions Comprising Non-Proteogenic Amino Acids and Methods of Treating Skin
10/14/2010US20100261754 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
10/14/2010US20100261749 Method of preventing or ameliorating psoriasis using pyrroloquinoline quinone compounds
10/14/2010US20100261746 Pharmaceutical formulation
10/14/2010US20100261745 Pharmaceutical formulation
10/14/2010US20100261744 Pharmaceutical formulation
10/14/2010US20100261728 Trp-m8 receptor ligands and their use in treatments
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261715 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
10/14/2010US20100261709 Pyridazinone derivatives as parp inhibitors
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261705 Carbostyril compound
10/14/2010US20100261691 Amorphous form of an anti-inflammatory compound
10/14/2010US20100261685 Personal care composition
10/14/2010US20100261670 Complexes of phosphate derivatives
10/14/2010US20100261659 Secreted frizzled related protein 3 for use in the inhibition of scarring
10/14/2010US20100261658 Peptide for activating aquaporin synthesis
10/14/2010US20100261654 Compositions and methods for increasing vascularization
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260835 Pharmaceutical composition
10/14/2010US20100260826 Patch and patch preparation
10/14/2010US20100260825 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
10/14/2010US20100260824 Antimicrobial Foam Compositions, Articles and Methods
10/14/2010US20100260823 Preparation with marine collagen for protease inhibition
10/14/2010US20100260812 Thickened fluid composition comprising chlorine dioxide
10/14/2010US20100260809 Preparation For Wound Healing And Prevention Of Bandage Adhesion To The Wound, Containing Chitosan-Glucan
10/14/2010US20100260782 NOVEL ANTI- Alpha 5 Beta 1 ANTIBODIES AND USES THEREOF
10/14/2010US20100260781 Treatment methods for autoimmune disorders
10/14/2010US20100260741 Factor VII or VIIa Polypeptide Variants
10/14/2010US20100260736 Egr1 modulators for the treatment of alopecia
10/14/2010US20100260722 Material for ameliorating skin tissue and method for producing the same
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010US20100260703 Injectable biodegradable polymer compositions for soft tissue repair and augmentation
10/14/2010US20100260702 Bioabsorbable and biocompatible polyurethanes and polyamides for medical devices
10/14/2010US20100260696 Aqueous Compositions Containing Alkoxylated Phosphoric Acid Triesters
10/14/2010US20100260694 Methionine Sulfoxide Peptide, Compositions And Methods Of Use
10/14/2010US20100260687 Personal care compositions including polyurethane dispersions
10/14/2010US20100260674 Quinazoline derivatives and methods of treatment
10/14/2010US20100260669 Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010CA2757534A1 Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof
10/14/2010CA2757466A1 Pharmaceutical composition for treating or preventing burn injuries
10/14/2010CA2754828A1 Method for preparing molecular complexes between adapalene and cyclodextrins
10/13/2010EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
10/13/2010EP2238981A1 Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser
10/13/2010EP2238980A1 Aqueous compositions containing metronidazole
10/13/2010EP2238977A2 Skin cleaning products
10/13/2010EP2238970A1 Emulsion preparation for external application to skin and cosmetic preparation
10/13/2010EP2238969A1 Preparation for external application to skin and cosmetic preparation
10/13/2010EP2237837A1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
10/13/2010EP2237786A2 Use of inhibitors of connexin43 for treatment of fibrotic conditions
10/13/2010EP2237775A1 Composition for topical use
10/13/2010EP2237772A2 Method and multilayered device for controlled topical delivery of therapeutic agents to the skin
10/13/2010EP1370537B1 Metalloproteinase inhibitors
1 ... 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 ... 1065